Understanding how cells maintain protein balance to prevent diseases.
Mechanisms regulating ER Proteostasis
This study is looking at how cells keep proteins from getting messed up, which can cause problems like cystic fibrosis and other diseases, and it hopes to find new ways to help people who struggle with these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11003746 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that help cells maintain proper protein folding and prevent the accumulation of misfolded proteins, which can lead to various diseases such as cystic fibrosis and neurodegeneration. The approach focuses on a newly identified system that regulates protein synthesis during its creation, aiming to enhance the quality control of proteins before they enter the cell's endoplasmic reticulum. By understanding these processes, the research seeks to identify potential therapeutic targets that could improve treatment options for patients suffering from protein misfolding disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with diseases related to protein misfolding, such as cystic fibrosis or neurodegenerative disorders.
Not a fit: Patients with conditions unrelated to protein misfolding or those who do not have any protein homeostasis disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or treat diseases caused by protein misfolding.
How similar studies have performed: Other research has shown promising results in understanding protein misfolding and its implications, but the specific approach of pre-emptive ER quality control is relatively novel.
Where this research is happening
Boston, United States
- Tufts University Boston — Boston, United States (Active)
Researchers
- Principal investigator: Raman, Malavika — Tufts University Boston
- Study coordinator: Raman, Malavika
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.